Veracyte EBITDA 2012-2025 | VCYT
Veracyte ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Veracyte Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $40 |
| 2023 | $-59 |
| 2022 | $-15 |
| 2021 | $-62 |
| 2020 | $-27 |
| 2019 | $-11 |
| 2018 | $-18 |
| 2017 | $-22 |
| 2016 | $-26 |
| 2015 | $-33 |
| 2014 | $-30 |
| 2013 | $-25 |
| 2012 | $-21 |
| 2011 | $-15 |
| Veracyte Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8 |
| 2024-12-31 | $10 |
| 2024-09-30 | $18 |
| 2024-06-30 | $10 |
| 2024-03-31 | $1 |
| 2023-12-31 | $-29 |
| 2023-09-30 | $-24 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $1 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-9 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-43 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-4 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-9 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-7 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-6 |
| 2012-12-31 | |
| 2012-09-30 | $-5 |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.847B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $179.321B | 21.70 |
| Intuitive Surgical (ISRG) | United States | $175.155B | 72.60 |
| Alcon (ALC) | Switzerland | $45.329B | 30.63 |
| Edwards Lifesciences (EW) | United States | $44.464B | 29.49 |
| IDEXX Laboratories (IDXX) | United States | $44.230B | 50.83 |
| IQVIA Holdings (IQV) | United States | $34.139B | 19.29 |
| DexCom (DXCM) | United States | $34.011B | 52.57 |
| Mettler-Toledo (MTD) | United States | $26.202B | 31.16 |
| STERIS (STE) | Ireland | $22.355B | 24.62 |
| Waters (WAT) | United States | $17.762B | 25.06 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.545B | 0.00 |
| Hologic (HOLX) | United States | $14.730B | 16.00 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $8.914B | 69.96 |
| Masimo (MASI) | United States | $8.750B | 32.28 |
| Globus Medical (GMED) | United States | $7.214B | 17.19 |
| Glaukos (GKOS) | United States | $5.393B | 0.00 |
| Teleflex (TFX) | United States | $5.135B | 8.48 |
| Integer Holdings (ITGR) | United States | $3.737B | 18.72 |
| TransMedics (TMDX) | United States | $3.612B | 78.52 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.360B | 14.06 |
| Nihon Kohden (NHNKY) | Japan | $2.146B | 24.61 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.566B | 0.00 |
| Artivion (AORT) | United States | $1.326B | 124.20 |
| OPKO Health (OPK) | United States | $1.110B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.028B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.000B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.988B | 5.25 |
| SiBone (SIBN) | United States | $0.740B | 0.00 |
| IRadimed (IRMD) | United States | $0.720B | 36.52 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| AxoGen (AXGN) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.549B | 8.55 |
| Semler Scientific (SMLR) | United States | $0.536B | 11.54 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.440B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.409B | 9.51 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.364B | 0.00 |
| RxSight (RXST) | United States | $0.323B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.316B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.44 |
| CVRx (CVRX) | United States | $0.214B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.204B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Accuray (ARAY) | United States | $0.141B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.093B | 56.50 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.069B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.33 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.29 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |